Half Yearly Results of Cohance Lifesciences Ltd. (Figures in Rs crores)

	Mar 31, 2026	Sep 30, 2025	Mar 31, 2025	Sep 30, 2024	Mar 31, 2024
Net Sales / Income	1,049.13	981.37	605.56	458.15	456.35
Other Income	5.33	39.40	21.81	31.38	30.83
Net Profit/Loss	81.85	146.86	130.69	141.40	105.80
Raw Material	327.92	363.35	122.09	73.90	123.81
Power And Fuel	0	0	0	0	0
Employee Expenses	181.90	198.53	103.06	87.42	67.72
Excise
Admin And Selling Expenses	0	0	0	0	0
Research And Devlopment Expenses	0	0	0	0	0
Expenses Capitalised	0	0	0	0	0
Other Expenses	279.56	263.41	142.09	83.97	101.13
Provisions Made	0	0	0	0	0
Interest	10.42	12.04	4.90	3.07	3.56
Gross Profit	214.26	262.42	199.55	212.36	167.56
Depreciation	71.02	62.56	28.63	24.29	27
Taxation	40.02	44.90	40.23	46.67	34.76
Extra Ordinary Item	-21.37	-8.10	0	0	0
Prior Year Adjustments	0	0	0	0	0
Equity Capital	38.26	38.26	25.46	25.46	25.46
Equity Dividend Rate	0	0	0	0	0
Agg.Of Non-Prom. Shares (in lacs)	0	0	0	0	0
Agg.Of Non PromotoHolding (%)	0	0	0	0	0
EPS (in Rs.)	2.14	3.84	5.13	5.55	4.16

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article